Human medicines

Fragmin

Replacement | Medicines | 03/02/2011

The marketing authorization holder informed its supplied customers in a letter dated February 3, 2011, that empty or almost empty prefilled syringes…

Fragmin Read more

Pegasys

Recall | Medicines | 26/01/2011

The marketing authorization holder has informed its supplied customers in a letter dated January 25, 2011, that cracks have been detected in the cone…

Pegasys Read more

Ebixa

Replacement | Medicines | 26/01/2011

The marketing authorization holder, in agreement with the European Medicines Agency (EMA), has informed the wholesalers supplied that all batches with…

Ebixa Read more

Dianeal

Recall | Medicines | 05/01/2011

Two batches of the product Dianeal have been identified that may contain endotoxins. Therefore, the marketing authorization holder has decided to…

Dianeal Read more

Nutrineal

Recall | Medicines | 23/12/2010

The marketing authorization holder has received increased adverse reactions (aseptic peritonitis) to the above batch. Therefore, Baxter Healthcare has…

Nutrineal Read more

Glucobene tablets

Recall | Medicines | 21/12/2010

The marketing authorization holder informed its supplied customers in a fax transmission on December 20, 2010, that due to complaints on the German…

Glucobene tablets Read more

Myocholine-Glenwood Tablets

Recall | Medicines | 15/12/2010

The distribution partner Croma-Pharma has informed the supplied customers by letter dated December 9, 2010, that the above mentioned batches have to…

Myocholine-Glenwood Tablets Read more

Migradon

Replacement | Medicines | 13/12/2010

The marketing authorization holder informed its supplied customers in a letter dated December 13, 2010, that the affected batch exhibited significant…

Migradon Read more

PegIntron

Recall | Medicines | 29/11/2010

The marketing authorization holder informed its supplied customers by letters dated October 29 and November 25, 2010, that the sterility of the…

PegIntron Read more

Velcade

Replacement | Medicines | 18/11/2010

The marketing authorization holder has informed its supplied customers by letter dated 18.11.2010 that due to 5 complaints about visible particles…

Velcade Read more
Email

Further inquiry note